Placement of Space<scp>OAR</scp> hydrogel spacer for prostate cancer patients treated with iodine‐125 low‐dose‐rate brachytherapy

Abstract

Prostate deformation secondary to hydrogel placement might adversely affect dosimetric parameters in patients undergoing low-dose-rate brachytherapy. However, a significant reduction in the rectal dose can be adopted without adversely affecting the other parameters related to treatment outcome.